Skip to main content
. 2021 Apr 28;36(8):1853–1862. doi: 10.1002/mds.28596

FIG 2.

FIG 2

Percentages of patients with reported Parkinson's disease medication usage before initiation of levodopa‐carbidopa intestinal gel (LCIG) and as add‐on therapy over time by class. All patients (A), LCIG monotherapy (B), LCIG daytime monotherapy (C), and LCIG polytherapy (D). “Levodopa” indicates oral formulations. COMT, catechol‐O‐methyl‐transferase; MAO‐B, monoamine oxidase‐B, NMDA, N‐methyl D‐aspartate.